Iron Therapeutics in Women’s Health: Past, Present, and Future
Open Access
- 8 December 2020
- journal article
- review article
- Published by MDPI AG in Pharmaceuticals
- Vol. 13 (12) , 449
Abstract
Iron plays a unique physiological role in the maintenance of homeostasis and the pathological outcomes of the female reproductive tract. The dual nature of elemental iron has created an evolutionary need to tightly regulate its biological concentration. The female reproductive tract is particularly unique due to the constant cycle of endometrial growth and shedding, in addition to the potential need for iron transfer to a developing fetus. Here, iron regulation is explored in a number of physiologic states including the endometrial lining and placenta. While iron dysregulation is a common characteristic in many women’s health pathologies there is currently a lack of targeted therapeutic options. Traditional iron therapies, including iron replacement and chelation, are common treatment options for gynecological diseases but pose long term negative health consequences; therefore, more targeted interventions directed towards iron regulation have been proposed. Recent findings show potential benefits in a therapeutic focus on ferritin-hepcidin regulation, modulation of reactive oxygen species (ROS), and iron mediated cell death (ferroptosis). These novel therapeutics are the direct result of previous research in iron’s complex signaling pathway and show promise for improved therapy, diagnosis, and prognosis in women’s health.Keywords
This publication has 162 references indexed in Scilit:
- A Promise in the Treatment of Endometriosis: An Observational Cohort Study on Ovarian Endometrioma Reduction by N-AcetylcysteineEvidence-Based Complementary and Alternative Medicine, 2013
- Malnutrition in Sub-Saharan Africa: burden, causes and prospectsPan African Medical Journal, 2013
- Hepcidin: A Critical Regulator of Iron Metabolism during HypoxiaAdvances in Hematology, 2011
- Crosstalk between Iron Metabolism and ErythropoiesisAdvances in Hematology, 2010
- Iron and Menopause: Does Increased Iron Affect the Health of Postmenopausal Women?Antioxidants & Redox Signaling, 2009
- Mucosal Immunization with Iron Receptor Antigens Protects against Urinary Tract InfectionPLOS Pathogens, 2009
- Hepcidin, a key regulator of iron metabolism, is transcriptionally activated by p53British Journal of Haematology, 2007
- Iron and pregnancy—a delicate balanceAnnals of Hematology, 2006
- Dietary iron intake and Type 2 diabetes incidence in postmenopausal women: the Iowa Women’s Health StudyDiabetologia, 2004
- Acute-Phase Proteins and Other Systemic Responses to InflammationNew England Journal of Medicine, 1999